... effect modifiers of the association of fat intake andriskofbreast cancer. Cancer Causes Control, 8, pp49-56.18 Collaborative Group on Hormonal Factors in BreastCancer (1997). Breastcancer ... protective role of pregnancy in breast cancer. Breast Cancer Res., 7(3), pp131-42.20 Collaborative Group on Hormonal Factors in BreastCancer (2002b). Breastcancerand breastfeeding: collaborative ... care cosmetics adversely affect breastcancer incidence in women? J Appl Toxicol., 24(3), pp167-176. 7 BREAST CANCER Environmental factors2. Breast cancer is caused by a combination of hormonal,...
... CRP concentration had aKang YA, et al. C- reactiveproteinand procalcitonin for the diagnosis of tuberculosis 339Table 1. Clinical and laboratory characteristics of the participantsBacterial ... non-AIDSimmunocompromised patients. Int J Tuberc Lung Dis 2003;7:Kang YA, et al. C- reactiveproteinand procalcitonin for the diagnosis of tuberculosis 341 Role of C- ReactiveProteinand Procalcitonin ... percentages.Figure 2. C- reactiveprotein (CRP) and procalcitonin (PCT) concentration according to the pneumonia severity index in bacterialcommunity-acquired pneumonia. Patients in risk classes...
... for controlling the risk factors for breastcancer through a collective and multisectoral policy.PreventionAlthough breastcancer cannot be prevented, the risks of developing breastcancer can ... Any form ofbreastcancer with distance metastasis 13%Source: [17]. Cancer detection programmes 25a) Characteristics of the cancer The cancer that is screened should have significant and serious ... Additional components in evaluating the efficacy ofbreastcancer screening programmes are:ã compliance rate;ã cancer detection rate;ã rate of detection of advanced cancers, including tumour size and...
... get breast cancer. n A woman’s riskofbreastcancer increases with age.n Two different medicines can lower the riskof some kinds of breast cancer. n Both medicines have side effects and sometimes ... body. Some breast cancers use estrogen to grow. There is a place on some breast cancer cells, called a receptor, where estrogen can attach. This type of breast cancer is called estrogen-receptor ... why this is the case. Maybe the medicines reduce thekinds ofbreast cancers that are easiest to treat. BreastCancerRisk FactorsAgeGetting older raises the riskofbreast cancer. Family historyHaving...
... Clinical application of C- reactiveprotein for cardiovascular diseasedetection and prevention. Circulation 2003;107:363-9.9. Ridker PM, Hennekens CH, Buring JE,Rifai N. C- reactiveproteinand ... Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 2003;290:1624-32.Copyright â 2007 Massachusetts ... particular characteristics of this population. Although patients with ischemic left ventricular systolic dysfunction have high rates of adverse outcomes, their riskof ischemic cardio-vascular...
... inlocally advanced breastcancer patients. Additional workis necessary to elucidate the specific mechanisms bywhich the androgens and AR influences breast cancer cells proliferation and apoptosis. ... B,Durocher F, Abeliovich D, Peretz T, Eeles RA: CAG and GGC repeatpolymorphisms in the androgen receptor gene andbreast cancer susceptibility in BRCA1/2 carriers and non-carriers. Br J Cancer ... Saxena2,3AbstractBackground: Considerably little is known about the biological role and clinical significance of androgen receptorexpression in breast cancer. The objectives of this study were to characterize...
... sus-pected cancer, the primary site of malignancy was 893 suf-fered from breast cancer, 428 from head and neck cancersexcluding thyroid cancer, 311 from gastrointestinal can-cers, 306 from lung cancer, ... purely cystic nodules, hyperechoicnodules, sharp margination, coarse calcification and peripheral vascularity [13]. US features associated withmalignancy are microcalcifications, hypoechoic nodules,irregular ... Byung Joo Chae - bjchae@gmail.com; Woo Chan Park - wcpark@catholic.ac.kr; Jeong Soo Kim - drbreast@catholic.ac.kr; Sung Hoon Kim - sghnk@catholic.ac.kr; Sang Seol Jung - ssjung@catholic.ac.kr; Byung...
... Stenkvist B: Breast cancer: prognosticsignificance of c- erb-B2 and int-2 amplification compared with DNAploidy, S-phase fraction, and conventional clinicopathological features. Breast Cancer Res ... Lin MT, Lin BR, Chang CC, Chu CY, Su HJ, Chen ST, Jeng YM, Kuo ML: IL-6induces AGS gastric cancer cell invasion via activation of the c- Src/RhoA/ROCK signaling pathway. Int J Cancer 2007, 120:2600-2608.doi:10.1186/1477-7819-9-18Cite ... 120:2600-2608.doi:10.1186/1477-7819-9-18Cite this article as: Ravishankaran and Karunanithi: Clinical significance of preoperative serum interleukin-6 and C- reactiveprotein level in breast cancer patients. World Journal of Surgical...
... Amsterdam2AbstractObjective: High-sensitivity C- reactiveprotein (hs-CRP) rises with cardiac injury/ischemia. We evaluated its efficacy inaiding in the identification of an acute coronary syndrome (ACS) ... (ED) with chest pain is a continuingchallenge. Of primary concern is recognition or exclu-sion of an acute coronary syndrome (ACS), which isinitiated with risk stratification that encompasses ... (57.7)ACS, acute coronary syndrome; SD, standard deviation; CAD, coronary arterydisease; ECG, electrocardiogram0 50 100 150hsCRPNo ACSACSFigure 1 hs-CRP values in presence of acute coronary...
... C- reactiveprotein in atherosclerosis: A causal factor? Cardiovasc Res. 2006; 71: 30-39. 24. Yip HK, Sun CK, Chang LT, Chen MC, Liou CW. Time course and prognostic value of plasma levels of ... ischemic stroke in patients with cerebrovascular disease. Arch Neurol. 2006; 63: 60-65. 10. Rost NS, Wolf PA, Kase CS, et al. Plasma concentration of C- reactiveproteinandriskof ischemic stroke ... Among ischemic strokes 6 were cardioembolic, 7 were lacunar, and the remainder (16) were ischemic non-cardioembolic (11 atherosclerotic and 5 of undetermined cause). The location of stroke...
... lifetime riskof secondary contralateral breast orlung cancers.For the clinical case used in this study the incremental risk of secondary cancerbreastcancer is calculated0.34% for a whole breast ... clini-cal significance of scattered dose one can refer to thecritical review published by Eric Hall in 2005 about theincreased riskof secondary cancers using conformalIMRT instead of 3D-CRT [5]. ... directions and without shielding fromthe192Ir source. The riskof secondary lung cancer cal-culated i n this case is increased by a factor 4, with 2 in100 women at riskof developing lung cancer. Regarding...